Sedation at the end of life - a nation-wide study in palliative care units in Austria
Authors:
- on behalf of the AUPACS (Austrian Palliative Care Study) GroupOGon behalf of the AUPACS (Austrian Palliative Care Study) Group
- Sophie SchurSSSophie Schur
- Gudrun KreyeGudrun Kreye
- Eva Katharina MaselEMEva Katharina Masel
- Kathrin KirchheinerKKKathrin Kirchheiner
Open Access
- 14 May 2016
- journal article
- research article
- Published by Springer Nature in BMC Palliative Care
- Vol. 15 (1) , 1-8
Abstract
Sedation is used to an increasing extent in end-of-life care. Definitions and indications in this field are based on expert opinions and case series. Little is known about this practice at palliative care units in Austria. Patients who died in Austrian palliative care units between June 2012 and June 2013 were identified. A predefined set of baseline characteristics and information on sedation during the last two weeks before death were obtained by reviewing the patients’ charts. The data of 2414 patients from 23 palliative care units were available for analysis. Five hundred two (21 %) patients received sedation in the last two weeks preceding their death, 356 (71 %) received continuous sedation until death, and 119 (24 %) received intermittent sedation. The median duration of sedation was 48 h (IQR 10–72 h); 168 patients (34 %) were sedated for less than 24 h. Indications for sedation were delirium (51 %), existential distress (32 %), dyspnea (30 %), and pain (20 %). Midazolam was the most frequently used drug (79 %), followed by lorazepam (13 %), and haloperidol (10 %). Sedated patients were significantly younger (median age 67 years vs. 74 years, p ≤ 0.001, r = 0.22), suffered more often from an oncological disease (92 % vs. 82 %, p ≤ 0.001, φ = 0.107), and were hospitalized more frequently (94 % vs. 76 %, p ≤ 0.001, φ = 0.175). The median number of days between admission to a palliative care ward/mobile palliative care team and death did not differ significantly in sedated versus non-sedated patients (10 vs. 9 days; p = 0.491). This study provides insights into the practice of end-of-life sedation in Austria. Critical appraisal of these data will serve as a starting point for the development of nation-wide guidelines for palliative sedation in Austria.Keywords
This publication has 31 references indexed in Scilit:
- Trends in end-of-life practices before and after the enactment of the euthanasia law in the Netherlands from 1990 to 2010: a repeated cross-sectional surveyThe Lancet, 2012
- Palliative Sedation in End-of-Life Care and Survival: A Systematic ReviewJournal of Clinical Oncology, 2012
- Symptom burden and performance status in a population‐based cohort of ambulatory cancer patientsCancer, 2010
- National Hospice and Palliative Care Organization (NHPCO) Position Statement and Commentary on the Use of Palliative Sedation in Imminently Dying Terminally Ill PatientsJournal of Pain and Symptom Management, 2010
- Palliative sedation therapy does not hasten death: results from a prospective multicenter studyAnnals of Oncology, 2009
- Continuous Deep Sedation: Physicians' Experiences in Six European CountriesJournal of Pain and Symptom Management, 2006
- When Nothing Helps: Propofol as Sedative and Antiemetic in Palliative Cancer CareJournal of Pain and Symptom Management, 2005
- Implementing Institutional Change: An Institutional Case Study of Palliative SedationJournal of Palliative Medicine, 2005
- Differences in physician-reported practice in palliative sedation therapySupportive Care in Cancer, 2004
- Sedation for symptom control in Japan: The importance of intermittent use and communication with family membersJournal of Pain and Symptom Management, 1996